Surprise Castle
Diet and Cancer: Markers, Prevention, and Treatment

Diet and Cancer: Markers, Prevention, and Treatment - Hardcover

$168.99
$169.99
-1%
Quantity
01

Pay over time for orders over $35.00 with

Offers & Perks

Earn 168 points with this purchase

Added to your rewards balance after checkout.

100 points welcome bonus

Create an account and start with extra points.

Join now

Availability:In StockContributor:Maryce M. JacobsSeries:Advances in Experimental Medicine and BiologyPublish date:5/31/1994Pages:256

The American Institute for Cancer Research (AICR) sponsored its third annual confer- ence on nutrition and cancer. The theme was "Diet and Cancer: Markers, Prevention, and Treatment. " The conference was held October 29-30, 1992 at the Ritz Carlton Hotel in McLean, Virginia. This proceedings contains chapters from the platform presentations and abstracts from the poster presentations. Several chapters address each of four session topics: Retinoids as Differentiation Agents in Cancer Therapy, Biological Markers of Cancer Risk, Chemoprevention of Cancer by Non-Nutrients in Foods, and Nutritional Problems and Support in the Treatment of Cancer. The first three chapters discuss in detail different mechanisms by which retinoids influence differentiation and provide evidence to support their use in cancer therapy. In vivo and in vitro studies show the effects of retinoic acid (RA) on tumorigenicity and cellu- lar/molecular events. A synopsis of data showing the involvement of the retinoblastoma (RB) gene in HL-60 cell differentiation induced by RA and 1,2S-dihydroxy vitamin D3 (VD) is presented. In SCID (severe combined immunodeficiency) mice injected with HL-60 3 human leukemia cells and gavaged daily with RA, the number of tumor sites and number of mice with tumors are reduced. All trans-RA induces myeloid differentiation in HL-60 cells. Similarly, VD3 induces HL-60 monocytic differentiation. In both cases an early down regulation of retinoblastoma (RB) gene expression precedes the differentiation.